Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC439

Belantamab mafodotin

  • Status:
    Veitt
  • Application date:
    7.9.2023
  • Application published:
    15.10.2023
  • Grant published:
    15.12.2025
  • Max expiry date:
    24.8.2035
  • Medicine name:
    Blenrep
  • Medicine for children:
    No

Timeline

Today
7.9.2023Application
15.10.2023Publication
15.12.2025Registration
24.8.2035Expires

Marketing license

  • IS authorization number:
    EU/1/20/1474
  • Date:
    14.9.2020
  • Foreign authorization number:
    EU/1/20/1474/001
  • Date:
    25.8.2020

Owner

  • Name:
    Glaxo Group Limited
  • Address:
    GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY GB

Agent

  • Name:
    Tego IP ehf.
  • Address:
    Pósthólf 8129, 128 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 15.10.2025

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents